23 results on '"Mäusezahl, Mirjam"'
Search Results
2. How much should we sequence? An analysis of the Swiss SARS-CoV-2 surveillance effort
- Author
-
Wegner, Fanny; https://orcid.org/0000-0003-4348-5872, Cabrera-Gil, Blanca, Tanguy, Araud, Beckmann, Christiane, Beerenwinkel, Niko, Bertelli, Claire; https://orcid.org/0000-0003-0550-8981, Carrara, Matteo, Cerutti, Lorenzo, Chen, Chaoran, Cordey, Samuel, Dumoulin, Alexis, du Plessis, Louis, Friedli, Marc, Gerth, Yannick, Greub, Gilbert; https://orcid.org/0000-0001-9529-3317, Härri, Adrian, Hirsch, Hans; https://orcid.org/0000-0003-0883-0423, Howald, Cedric, Huber, Michael, Imhof, Alexander, Kaiser, Laurent, Kufner, Verena, Leib, Stephen L; https://orcid.org/0000-0002-1106-6123, Leuzinger, Karoline; https://orcid.org/0000-0002-5654-9356, Lleshi, Etleva, Martinetti, Gladys, Mäusezahl, Mirjam, Neher, Richard; https://orcid.org/0000-0003-2525-1407, Trkola, Alexandra; https://orcid.org/0000-0003-1013-876X, Egli, Adrian; https://orcid.org/0000-0002-3564-8603, et al, SPSP consortium, Wegner, Fanny; https://orcid.org/0000-0003-4348-5872, Cabrera-Gil, Blanca, Tanguy, Araud, Beckmann, Christiane, Beerenwinkel, Niko, Bertelli, Claire; https://orcid.org/0000-0003-0550-8981, Carrara, Matteo, Cerutti, Lorenzo, Chen, Chaoran, Cordey, Samuel, Dumoulin, Alexis, du Plessis, Louis, Friedli, Marc, Gerth, Yannick, Greub, Gilbert; https://orcid.org/0000-0001-9529-3317, Härri, Adrian, Hirsch, Hans; https://orcid.org/0000-0003-0883-0423, Howald, Cedric, Huber, Michael, Imhof, Alexander, Kaiser, Laurent, Kufner, Verena, Leib, Stephen L; https://orcid.org/0000-0002-1106-6123, Leuzinger, Karoline; https://orcid.org/0000-0002-5654-9356, Lleshi, Etleva, Martinetti, Gladys, Mäusezahl, Mirjam, Neher, Richard; https://orcid.org/0000-0003-2525-1407, Trkola, Alexandra; https://orcid.org/0000-0003-1013-876X, Egli, Adrian; https://orcid.org/0000-0002-3564-8603, et al, and SPSP consortium
- Abstract
During the SARS-CoV-2 pandemic, many countries directed substantial resources toward genomic surveillance to detect and track viral variants. There is a debate over how much sequencing effort is necessary in national surveillance programs for SARS-CoV-2 and future pandemic threats. We aimed to investigate the effect of reduced sequencing on surveillance outcomes in a large genomic data set from Switzerland, comprising more than 143k sequences. We employed a uniform downsampling strategy using 100 iterations each to investigate the effects of fewer available sequences on the surveillance outcomes: (i) first detection of variants of concern (VOCs), (ii) speed of introduction of VOCs, (iii) diversity of lineages, (iv) first cluster detection of VOCs, (v) density of active clusters, and (vi) geographic spread of clusters. The impact of downsampling on VOC detection is disparate for the three VOC lineages, but many outcomes including introduction and cluster detection could be recapitulated even with only 35% of the original sequencing effort. The effect on the observed speed of introduction and first detection of clusters was more sensitive to reduced sequencing effort for some VOCs, in particular Omicron and Delta, respectively. A genomic surveillance program needs a balance between societal benefits and costs. While the overall national dynamics of the pandemic could be recapitulated by a reduced sequencing effort, the effect is strongly lineage-dependent-something that is unknown at the time of sequencing-and comes at the cost of accuracy, in particular for tracking the emergence of potential VOCs.IMPORTANCESwitzerland had one of the most comprehensive genomic surveillance systems during the COVID-19 pandemic. Such programs need to strike a balance between societal benefits and program costs. Our study aims to answer the question: How would surveillance outcomes have changed had we sequenced less? We find that some outcomes but also certain viral lineages are more af
- Published
- 2024
3. Serotypes and virulence profiles of Shiga toxin-producing Escherichia coli strains isolated during 2017 from human infections in Switzerland
- Author
-
Nüesch-Inderbinen, Magdalena, Morach, Marina, Cernela, Nicole, Althaus, Denise, Jost, Marianne, Mäusezahl, Mirjam, Bloomberg, Guido, and Stephan, Roger
- Published
- 2018
- Full Text
- View/download PDF
4. The Swiss Pathogen Surveillance Platform – towards a nation-wide One Health data exchange platform for bacterial, viral and fungal genomics and associated metadata
- Author
-
Neves, Aitana, primary, Walther, Daniel, additional, Martin-Campos, Trinidad, additional, Barbie, Valerie, additional, Bertelli, Claire, additional, Blanc, Dominique, additional, Bouchet, Gérard, additional, Erard, Frédéric, additional, Greub, Gilbert, additional, Hirsch, Hans H., additional, Huber, Michael, additional, Kaiser, Laurent, additional, Leib, Stephen L., additional, Leuzinger, Karoline, additional, Lazarevic, Vladimir, additional, Mäusezahl, Mirjam, additional, Molina, Jorge, additional, Neher, Richard A., additional, Perreten, Vincent, additional, Ramette, Alban, additional, Roloff, Tim, additional, Schrenzel, Jacques, additional, Seth-Smith, Helena M. B., additional, Stephan, Roger, additional, Terumalai, Dillenn, additional, Wegner, Fanny, additional, and Egli, Adrian, additional
- Published
- 2023
- Full Text
- View/download PDF
5. The Swiss Pathogen Surveillance Platform - towards a nation-wide One Health data exchange platform for bacterial, viral and fungal genomics and associated metadata
- Author
-
Neves, Aitana, Walther, Daniel, Martin-Campos, Trinidad, Barbie, Valerie, Bertelli, Claire, Blanc, Dominique, Bouchet, Gérard, Erard, Frédéric, Greub, Gilbert, Hirsch, Hans H, Huber, Michael, Kaiser, Laurent, Leib, Stephen L, Leuzinger, Karoline, Lazarevic, Vladimir, Mäusezahl, Mirjam, Molina, Jorge, Neher, Richard A, Perreten, Vincent, Ramette, Alban, Roloff, Tim, Schrenzel, Jacques, Seth-Smith, Helena M B, Stephan, Roger, Terumalai, Dillenn, Wegner, Fanny, and Egli, Adrian
- Subjects
630 Agriculture ,570 Life sciences ,biology ,610 Medicine & health ,General Medicine - Abstract
The Swiss Pathogen Surveillance Platform (SPSP) is a shared secure surveillance platform between human and veterinary medicine, to also include environmental and foodborne isolates. It enables rapid and detailed transmission monitoring and outbreak surveillance of pathogens using whole genome sequencing data and associated metadata. It features controlled data access, complex dynamic queries, dedicated dashboards and automated data sharing with international repositories, providing actionable results for public health and the vision to improve societal well-being and health.
- Published
- 2023
- Full Text
- View/download PDF
6. Parental and provider vaccine hesitancy and non-timely childhood vaccination in Switzerland
- Author
-
Jafflin, Kristen, Deml, Michael J, Schwendener, Corina L, Kiener, Laura, Delfino, Alexandre, Gafner, Rebecca, Schudel, Sophie, Mäusezahl, Mirjam, Berger, Christoph, Huber, Benedikt M, Merten, Sonja, Tarr, Philip E, University of Zurich, and Tarr, Philip E
- Subjects
Parents ,Health Knowledge, Attitudes, Practice ,General Veterinary ,General Immunology and Microbiology ,3400 General Veterinary ,Environmental and Occupational Health ,Vaccination ,Public Health, Environmental and Occupational Health ,610 Medicine & health ,2739 Public Health, Environmental and Occupational Health ,2725 Infectious Diseases ,Patient Acceptance of Health Care ,Infectious Diseases ,10036 Medical Clinic ,1313 Molecular Medicine ,2400 General Immunology and Microbiology ,Tetanus Toxoid ,Humans ,Molecular Medicine ,Public Health ,Vaccination Hesitancy ,Child ,Switzerland - Abstract
Although medical providers are a trusted vaccination information source for parents, they do not universally support vaccination. Complementary medicine (CM) providers are particularly likely to hold vaccine hesitant (VH) views, and VH parents often consult with them. Little research compares VH of parents and providers, and if and how each is associated with uptake of recommended childhood vaccines.We defined non-timely receipt as recommended vaccines given 1 month later than officially recommended, based on vaccination records. We administered versions of the Parent Attitudes about Childhood Vaccines (PACV) 5-item survey instrument to 1256 parents and their children's pediatricians (N = 112, 40 CM-oriented, 72 biomedical [not CM-oriented]) to identify moderately (PACV-score 5-6) and highly (PACV-score 7+) hesitant providers/parents. We obtained multivariable adjusted odds ratios to test relationships between parental VH and provider type/VH, and between non-timely receipt of selected childhood vaccines and parental VH and provider type/VH.No biomedical providers were VH, 9 CM providers were moderately VH, and 17 were highly VH. Parents seeing moderately and highly hesitant providers had adjusted odds ratio (AOR) for being VH = 6.6 (95% confidence interval (CI), 3.1-14.0) and AOR = 31.3 (95% CI 16.8-58.3), respectively. Across all vaccine uptake endpoints, children of moderately and highly hesitant parents had 1.9-3.8 and 7.1-12.3 higher odds of non-timely vaccination, and children seeing highly hesitant CM providers had 4.9-9.4 higher odds. Children seeing moderately hesitant CM providers had 3.3 higher odds of non-timely vaccination for the 1st dose of measles and 3.5 higher odds for 1st dose of polio/pertussis/tetanus.VH by both parents and providers each is associated with non-timely childhood vaccination. As VH parents are more likely to consult with VH providers, interventions aimed at increasing timely vaccination need to primarily target VH providers and their clients.
- Published
- 2022
- Full Text
- View/download PDF
7. Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland
- Author
-
Walti, Laura N, Mugglin, Catrina, Mombelli, Matteo, Manuel, Oriol, Hirsch, Hans H, Khanna, Nina, Mueller, Nicolas J, Berger, Christoph, Boggian, Katia, Garzoni, Christian, Neofytos, Dionysios, van Delden, Christian, Mäusezahl, Mirjam, Hirzel, Cédric, Swiss Transplant Cohort Study, Walti, Laura N, Mugglin, Catrina, Mombelli, Matteo, Manuel, Oriol, Hirsch, Hans H, Khanna, Nina, Mueller, Nicolas J, Berger, Christoph, Boggian, Katia, Garzoni, Christian, Neofytos, Dionysios, van Delden, Christian, Mäusezahl, Mirjam, Hirzel, Cédric, and Swiss Transplant Cohort Study
- Abstract
IMPORTANCE Vaccine responses are decreased in solid organ transplant (SOT) recipients, and given the complexity of implementation, vaccination programs may be suboptimal. The actual burden of vaccine-preventable infections (VPIs) among SOT recipients remains unclear. OBJECTIVES To assess the incidence rate of VPIs among SOT recipients and to evaluate whether SOT recipients are at increased risk for specific VPIs compared with the general population. DESIGN, SETTING, AND PARTICIPANTS This nationwide cohort study used data from the Swiss Transplant Cohort Study on VPIs in individuals who underwent SOT from May 2008 to June 2019 (follow-up until December 2019) and data from the Swiss Federal Office of Public Health on notifiable VPIs in the general population in the same period. Data were analyzed from January 2021 to June 2022. EXPOSURES Solid organ transplant. MAIN OUTCOMES AND MEASURES The main outcomes were the incidence rate of the following VPIs in SOT recipients: hepatitis A and B, diphtheria, Haemophilus influenzae infection, influenza, measles, mumps, pertussis, pneumococcal disease, poliomyelitis, meningococcal disease, rubella, tetanus, tick-borne encephalitis, and varicella zoster virus infection. Age-adjusted standardized incidence ratios were used to assess whether VPIs occurred more frequently in SOT recipients compared with the general population. For SOT recipients, factors associated with occurrence of VPIs were explored and the associated morbidity and mortality assessed. RESULTS Of 4967 SOT recipients enrolled (median age, 54 years [IQR, 42-62 years]; 3191 [64.2%] male), 593 (11.9%) experienced at least 1 VPI. The overall VPI incidence rate was higher in the population that underwent SOT (30.57 per 1000 person-years [PY]; 95% CI, 28.24-33.10 per 1000 PY) compared with the general population (0.71 per 1000 PY). The standardized age-adjusted incidence ratio for notifiable VPIs in SOT recipients was higher compared with the general population (27.84; 9
- Published
- 2023
8. A 5-Year Comparison of Performance of Sentinel and Mandatory Notification Surveillance Systems for Measles in Switzerland
- Author
-
Richard, Jean-Luc, Vidondo, Beatriz, and Mäusezahl, Mirjam
- Published
- 2008
- Full Text
- View/download PDF
9. Surveillance Systems for Sexually Transmitted Diseases in Switzerland
- Author
-
ZWAHLEN, MARCEL, SPOERRI, ADRIAN, GEBHARDT, MARTIN, MÄUSEZAHL, MIRJAM, BOUBAKER, KARIM, and LOW, NICOLA
- Published
- 2007
10. Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: an observational study from routine surveillance data in Switzerland
- Author
-
Anderegg, Nanina, primary, Althaus, Christian L., additional, Colin, Samuel, additional, Hauser, Anthony, additional, Laube, Anne, additional, Mäusezahl, Mirjam, additional, Wagner, Moritz, additional, Zaffora, Biagio, additional, and Riou, Julien, additional
- Published
- 2022
- Full Text
- View/download PDF
11. Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection from routine surveillance data in Switzerland
- Author
-
Anderegg, Nanina, primary, Althaus, Christian L, additional, Colin, Samuel, additional, Hauser, Anthony, additional, Laube, Anne, additional, Mäusezahl, Mirjam, additional, Wagner, Moritz, additional, Zaffora, Biagio, additional, and Riou, Julien, additional
- Published
- 2021
- Full Text
- View/download PDF
12. Listeriosis in infants: Prospective surveillance studies in Canada and Switzerland
- Author
-
Abu-Raya, Bahaa, primary, Jost, Marianne, additional, Bettinger, Julie A, additional, Bortolussi, Robert, additional, Grabowski, Janet, additional, Lacaze-Masmonteil, Thierry, additional, Robinson, Joan L, additional, Posfay-Barbe, Klara M, additional, Galanis, Eleni, additional, Schutt, Elizabeth, additional, Mäusezahl, Mirjam, additional, and Kollmann, Tobias R, additional
- Published
- 2021
- Full Text
- View/download PDF
13. Impfskepsis in der Schweiz –ein nationales Forschungsprogramm
- Author
-
Berger, Christoph, Deml, Michael, Mettraux, Valerie, Huber, Benedikt, Krüerke, Daniel, Wingeier, Bernhard, Gallmann, Caesar, Kliemb, Paulina, Fraub, Eleonora, Sonderegger, Joanna, Zeller, Andreas, Mäusezahl, Mirjam, Suggs, Suzanne, Jafflin, Kristen, Merten, Sonja, Burton-Jeangros, Claudine, and Tarr, Philip
- Published
- 2018
- Full Text
- View/download PDF
14. Health-seeking behaviour and treatment delay in patients with pulmonary tuberculosis in Switzerland: some slip through the net
- Author
-
Auer, Christian, primary, Kiefer, Sabine, additional, Zuske, Meike, additional, Schindler, Christian, additional, Wyss, Kaspar, additional, Blum, Johannes, additional, Bosch-Capblanch, Xavier, additional, Widmer, Ursula, additional, Sauthier, Sonia, additional, Janssens, Jean-Paul, additional, Bossard, Katharina, additional, Chatonnet, Christophe, additional, Mazza-Stalder, Jesica, additional, Začek, Bea, additional, Zellweger, Jean-Pierre, additional, Altpeter, Ekkehardt, additional, and Mäusezahl, Mirjam, additional
- Published
- 2018
- Full Text
- View/download PDF
15. Serotypes and virulence profiles of Shiga toxin-producing Escherichia coli strains isolated during 2017 from human infections in Switzerland
- Author
-
Nüesch-Inderbinen, Magdalena; https://orcid.org/0000-0002-3242-9739, Morach, Marina, Cernela, Nicole, Althaus, Denise, Jost, Marianne, Mäusezahl, Mirjam, Bloomberg, Guido, Stephan, Roger; https://orcid.org/0000-0003-1002-4762, Nüesch-Inderbinen, Magdalena; https://orcid.org/0000-0002-3242-9739, Morach, Marina, Cernela, Nicole, Althaus, Denise, Jost, Marianne, Mäusezahl, Mirjam, Bloomberg, Guido, and Stephan, Roger; https://orcid.org/0000-0003-1002-4762
- Abstract
Since 2015, the Swiss Federal Office of Public Health registered an increase of notifications of STEC, probably due to the adoption of culture independent stx screening tests in diagnostic laboratories. This study aimed to identify the serotypes and virulence genes of 120 STEC isolated from human clinical stx positive specimens during 2017 in order to estimate any changes in serotype distribution and toxin profiles of STEC compared to the time span 2010-2014. Culturing of STEC from stool samples was achieved using the streak plate technique on MacConkey agar. We performed O and H serotyping by PCR and by micro array. Virulence genes were identified and subtyped using molecular methods, including stx1 and stx2 subtypes, and the intimin encoding gene, eae. STEC were recovered from 27.5% of the stx positive samples. STEC O157:H7 accounted for 7.5% of all isolates, and STEC O80:H2, O91:H10/H14/H21, O103:H2/H11, and O26:H11 accounted for 36.9% of the non-O157 strains. Forty-five isolates with stx1 variants, 47 with stx2 variants and 28 isolates with both stx1 and stx2 variants were identified. Forty (33.3% of all isolates) carried the subtypes associated with high pathogenic potential, stx2a, stx2c, or stx2d. The eae gene for intimin was detected in 54 strains (45% of all strains). Compared to 2010-2014, our data show that the proportion of the so called "top five" serogroups, STEC O26, O111, O103, and O157 declined from 53.7% to 28.3% in 2017. The proportion of isolates with stx2a, stx2c, or stx2d decreased from 50.5% to 33.3%. We also observed an increase of STEC harbouring the low pathogenic subtypes stx2b and stx2e from 12.6% to 29.2%, and of eae negative STEC from 29.5% in 2010-2014 to 55% in 2017. Simultaneously, there was a sharp increase of the patients' median age from 24 years to 46.5 years. Clinical manifestations in the patients included abdominal pain without diarrhea (22.3%), diarrhea (77.7%), and the haemolytic-uremic syndrome (HUS) (7.4%). Our data show t
- Published
- 2018
16. Cross-border outbreak of Salmonella enterica ssp. enterica serovar Bovismorbificans: multiple approaches for an outbreak investigation in Germany and Switzerland
- Author
-
Knoblauch, Astrid M, Bratschi, Martin W, Zuske, Meike K, Althaus, Denise, Stephan, Roger, Hächler, Herbert, Baumgartner, Andreas, Prager, Rita, Rabsch, Wolfgang, Altpeter, Ekkehardt, Jost, Marianne, Mäusezahl, Mirjam, Hatz, Christoph, Kiefer, Sabine, University of Zurich, and Kiefer, Sabine
- Subjects
610 Medicine & health ,10060 Epidemiology, Biostatistics and Prevention Institute (EBPI) ,2700 General Medicine ,10082 Institute of Food Safety and Hygiene - Abstract
In July 2014, an outbreak of Salmonella enterica ssp. enterica serovar Bovismorbificans was detected in Switzerland. The goal of the outbreak investigation was to rapidly identify and eliminate the contamination source in order to prevent new cases.; A case-case study design was applied comprising reported cases of S. Bovismorbificans and cases of other serovars. A trawling questionnaire was administered by telephone interview. Data were collected for 34 cases (20 S. Bovismorbificans and 14 Salmonella spp.) pertaining to food consumption during the 72 hours prior to symptom onset.; A statistically significant association between an S. Bovismorbificans infection and the consumption of 'salads' (odds ratio [OR] 14.3, 95% confidence interval [CI] 1.47-138.27) as well as the consumption of 'sprouts' (OR 10.6, 95% CI 1.16-97.59) was found. Principal places of consumption of 'salads' and 'sprouts' in outbreak cases were restaurants in southern Germany (80.0%, 95% CI 56.3%-94.3%). Microbiological analysis in Germany identified S. Bovismorbificans on sprouts, and genotype analysis confirmed that Swiss and German cases shared the same outbreak strain. The contaminated products were removed from the market in Germany, preventing an on-going outbreak.; The combination of the applied methods and the collaboration between the two countries proved to be crucial elements of this investigation. A series of sprouts-associated salmonellosis outbreaks underpin the importance of this vegetable as a potential food-borne pathogen carrier.
- Published
- 2015
17. Vaccine-Preventable Infections Among Solid Organ Transplant Recipients in Switzerland.
- Author
-
Walti, Laura N., Mugglin, Catrina, Mombelli, Matteo, Manuel, Oriol, Hirsch, Hans H., Khanna, Nina, Mueller, Nicolas J., Berger, Christoph, Boggian, Katia, Garzoni, Christian, Neofytos, Dionysios, van Delden, Christian, Mäusezahl, Mirjam, and Hirzel, Cédric
- Published
- 2023
- Full Text
- View/download PDF
18. A 5-year comparison of performance of sentinel and mandatory notification surveillance systems for measles in Switzerland
- Author
-
Richard, Jean-Luc, primary, Vidondo, Beatriz, additional, and Mäusezahl, Mirjam, additional
- Published
- 2007
- Full Text
- View/download PDF
19. Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: an observational study from routine surveillance data in Switzerland
- Author
-
Anderegg, Nanina, Althaus, Christian L, Colin, Samuel, Hauser, Anthony, Laube, Anne, Mäusezahl, Mirjam, Wagner, Moritz, Zaffora, Biagio, and Riou, Julien
- Subjects
COVID-19 Vaccines ,SARS-CoV-2 ,360 Social problems & social services ,Child, Preschool ,COVID-19 ,Humans ,Vaccine Efficacy ,610 Medicine & health ,General Medicine ,Switzerland ,Aged - Abstract
BACKGROUND: In Switzerland, SARS-CoV-2 vaccination campaigns started in early 2021. Vaccine coverage reached 65% of the population in December 2021, mostly with mRNA vaccines from Moderna and Pfizer-BioNtech. Simultaneously, the proportion of vaccinated among COVID-19-related hospitalisations and deaths rose, creating some confusion in the general population. We aimed to assess vaccine effectiveness against severe forms of SARS-CoV-2 infection using routine surveillance data on the vaccination status of COVID-19-related hospitalisations and deaths, and data on vaccine coverage in Switzerland. METHODS: We considered all routine surveillance data on COVID-19-related hospitalisations and deaths received at the Swiss Federal Office of Public Health from 1 July to 1 December 2021. We estimated the relative risk of COVID-19-related hospitalisation or death for not fully vaccinated compared with fully vaccinated individuals, adjusted for the dynamics of vaccine coverage over time, by age and location. We stratified the analysis by age group and by calendar month. We assessed variations in the relative risk of hospitalisation associated with the time since vaccination. RESULTS: We included a total of 5948 COVID-19-related hospitalisations of which 1245 (21%) were fully vaccinated patients, and a total of 739 deaths of which 259 (35%) were fully vaccinated. We found that the relative risk of COVID-19 related hospitalisation was 12.5 (95% confidence interval [CI] 11.7–13.4) times higher for not fully vaccinated than for fully vaccinated individuals. This translates into a vaccine effectiveness against hospitalisation of 92.0% (95% CI 91.4–92.5%). Vaccine effectiveness against death was estimated to be 90.3% (95% CI 88.6–91.8%). Effectiveness appeared to be comparatively lower in age groups over 70 and during the months of October and November 2021. We also found evidence of a decrease in vaccine effectiveness against hospitalisation for individuals vaccinated for 25 weeks or more, but this decrease appeared only in age groups below 70. CONCLUSIONS: The observed proportions of vaccinated among COVD-19-related hospitalisations and deaths in Switzerland were compatible with a high effectiveness of mRNA vaccines from Moderna and Pfizer-BioNtech against hospitalisation and death in all age groups. Effectiveness appears comparatively lower in older age groups, suggesting the importance of booster vaccinations. We found inconclusive evidence that vaccine effectiveness wanes over time. Repeated analyses will be able to better assess waning and the effect of boosters.
- Full Text
- View/download PDF
20. How much should we sequence? An analysis of the Swiss SARS-CoV-2 surveillance effort.
- Author
-
Wegner F, Cabrera-Gil B, Tanguy A, Beckmann C, Beerenwinkel N, Bertelli C, Carrara M, Cerutti L, Chen C, Cordey S, Dumoulin A, du Plessis L, Friedli M, Gerth Y, Greub G, Härri A, Hirsch H, Howald C, Huber M, Imhof A, Kaiser L, Kufner V, Leib SL, Leuzinger K, Lleshi E, Martinetti G, Mäusezahl M, Moraz M, Neher R, Nolte O, Ramette A, Redondo M, Risch L, Rohner L, Roloff T, Schläepfer P, Schneider K, Singer F, Spina V, Stadler T, Studer E, Topolsky I, Trkola A, Walther D, Wohlwend N, Zehnder C, Neves A, and Egli A
- Subjects
- Humans, Switzerland epidemiology, Epidemiological Monitoring, Pandemics, Phylogeny, COVID-19 epidemiology, COVID-19 virology, COVID-19 diagnosis, SARS-CoV-2 genetics, SARS-CoV-2 isolation & purification, SARS-CoV-2 classification, Genome, Viral genetics
- Abstract
During the SARS-CoV-2 pandemic, many countries directed substantial resources toward genomic surveillance to detect and track viral variants. There is a debate over how much sequencing effort is necessary in national surveillance programs for SARS-CoV-2 and future pandemic threats. We aimed to investigate the effect of reduced sequencing on surveillance outcomes in a large genomic data set from Switzerland, comprising more than 143k sequences. We employed a uniform downsampling strategy using 100 iterations each to investigate the effects of fewer available sequences on the surveillance outcomes: (i) first detection of variants of concern (VOCs), (ii) speed of introduction of VOCs, (iii) diversity of lineages, (iv) first cluster detection of VOCs, (v) density of active clusters, and (vi) geographic spread of clusters. The impact of downsampling on VOC detection is disparate for the three VOC lineages, but many outcomes including introduction and cluster detection could be recapitulated even with only 35% of the original sequencing effort. The effect on the observed speed of introduction and first detection of clusters was more sensitive to reduced sequencing effort for some VOCs, in particular Omicron and Delta, respectively. A genomic surveillance program needs a balance between societal benefits and costs. While the overall national dynamics of the pandemic could be recapitulated by a reduced sequencing effort, the effect is strongly lineage-dependent-something that is unknown at the time of sequencing-and comes at the cost of accuracy, in particular for tracking the emergence of potential VOCs.IMPORTANCESwitzerland had one of the most comprehensive genomic surveillance systems during the COVID-19 pandemic. Such programs need to strike a balance between societal benefits and program costs. Our study aims to answer the question: How would surveillance outcomes have changed had we sequenced less? We find that some outcomes but also certain viral lineages are more affected than others by sequencing less. However, sequencing to around a third of the original effort still captured many important outcomes for the variants of concern such as their first detection but affected more strongly other measures like the detection of first transmission clusters for some lineages. Our work highlights the importance of setting predefined targets for a national genomic surveillance program based on which sequencing effort should be determined. Additionally, the use of a centralized surveillance platform facilitates aggregating data on a national level for rapid public health responses as well as post-analyses., Competing Interests: The authors declare no conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF
21. Approaching measles elimination in Switzerland: changing epidemiology 2007-2018.
- Author
-
Richard JL, Mäusezahl M, Basler S, and Eckert N
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Disease Notification, Disease Outbreaks prevention & control, Female, Humans, Incidence, Infant, Male, Measles prevention & control, Measles Vaccine therapeutic use, Switzerland epidemiology, Young Adult, Disease Eradication trends, Epidemics statistics & numerical data, Measles epidemiology, Population Surveillance, Vaccination statistics & numerical data
- Abstract
Switzerland is aiming to eliminate measles, in line with the objectives of the World Health Organization (WHO). Physicians, laboratories and public health authorities have made great efforts to reach this goal. A continually increasing measles vaccination coverage and other preventive measures have made an impact: no major measles outbreak has been recorded since 2011. In order to evaluate progress towards elimination, measles epidemiology of a previous epidemic period (2007–2011) was compared with the current post-epidemic period (2012–July 2018) by analysis of data from the mandatory notification system. A decrease of 94% in the average annual incidence rate occurred between the two periods (from 133 to 9 cases per million inhabitants). This was accompanied by significant changes in the epidemiology that are expected and characteristic of countries with limited circulation of the measles virus. After analysing the performance of the Swiss surveillance system and the data provided, the WHO concluded that endemic measles transmission was interrupted in Switzerland in 2016 and 2017.
- Published
- 2019
- Full Text
- View/download PDF
22. The epidemiology of hepatitis C in Switzerland: trends in notifications, 1988-2015.
- Author
-
Richard JL, Schaetti C, Basler S, and Mäusezahl M
- Subjects
- Adult, Female, Hepacivirus isolation & purification, Humans, Incidence, Male, Prevalence, Risk Factors, Sex Factors, Sexual Behavior, Substance Abuse, Intravenous, Switzerland epidemiology, Hepatitis C epidemiology, Population Surveillance methods
- Abstract
With an estimated antibody prevalence of 0.7% in the low-risk population, hepatitis C virus (HCV) endemicity in Switzerland is low. We reviewed data from mandatory hepatitis C surveillance for 1988-2015 in order to describe the evolution of acute HCV infections and newly reported non-acute cases, and their epidemiological features. Crude and stratified annual incidence and notification rates and rate ratios were calculated using Poisson regression. Acute HCV incidence peaked in 2002 at 1.8 cases per 100,000 population, then declined sharply, levelling at around 0.7/100,000 from 2006. Notification rates for non-acute HCV cases peaked in 1999 (38.6/100,000), decreasing to 16.8/100,000 in 2015. Men constituted 65.5% of acute cases and 60.4% of non-acute cases. During the periods 1992-1995 and 2012-2015, the median age of acute cases increased from 28 to 37 and of non-acute cases from 32 to 48 years. The exposure leading to most acute (90.4%) and non-acute (71.9%) cases was presumably in Switzerland. Despite a sharp decrease since 2000, injecting drugs was the main reported exposure for both acute (63.8%) and non-acute (66.6%) cases, with a known exposure, followed by sexual contact with an infected person (18.9% and 10.3% respectively). Among all acute cases, the number of men who have sex with men increased sharply after the mid-2000s, totalling 41 during 2012-2015 (25.7%). Although the HCV epidemic peaked in 2000 - probably as a result of measures to control iatrogenic and percutaneous transmission - Switzerland must maintain prevention and surveillance.
- Published
- 2018
- Full Text
- View/download PDF
23. Cross-border outbreak of Salmonella enterica ssp. enterica serovar Bovismorbificans: multiple approaches for an outbreak investigation in Germany and Switzerland.
- Author
-
Knoblauch AM, Bratschi MW, Zuske MK, Althaus D, Stephan R, Hächler H, Baumgartner A, Prager R, Rabsch W, Altpeter E, Jost M, Mäusezahl M, Hatz C, and Kiefer S
- Subjects
- Case-Control Studies, Germany epidemiology, Humans, Restaurants, Salmonella Food Poisoning microbiology, Switzerland epidemiology, Contact Tracing methods, Disease Outbreaks, International Cooperation, Salmonella Food Poisoning epidemiology, Salmonella enterica, Vegetables microbiology
- Abstract
Question Under Study: In July 2014, an outbreak of Salmonella enterica ssp. enterica serovar Bovismorbificans was detected in Switzerland. The goal of the outbreak investigation was to rapidly identify and eliminate the contamination source in order to prevent new cases., Methods: A case-case study design was applied comprising reported cases of S. Bovismorbificans and cases of other serovars. A trawling questionnaire was administered by telephone interview. Data were collected for 34 cases (20 S. Bovismorbificans and 14 Salmonella spp.) pertaining to food consumption during the 72 hours prior to symptom onset., Results: A statistically significant association between an S. Bovismorbificans infection and the consumption of 'salads' (odds ratio [OR] 14.3, 95% confidence interval [CI] 1.47-138.27) as well as the consumption of 'sprouts' (OR 10.6, 95% CI 1.16-97.59) was found. Principal places of consumption of 'salads' and 'sprouts' in outbreak cases were restaurants in southern Germany (80.0%, 95% CI 56.3%-94.3%). Microbiological analysis in Germany identified S. Bovismorbificans on sprouts, and genotype analysis confirmed that Swiss and German cases shared the same outbreak strain. The contaminated products were removed from the market in Germany, preventing an on-going outbreak., Conclusion: The combination of the applied methods and the collaboration between the two countries proved to be crucial elements of this investigation. A series of sprouts-associated salmonellosis outbreaks underpin the importance of this vegetable as a potential food-borne pathogen carrier.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.